{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:23:56Z","timestamp":1793057036223,"version":"4.5.0"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T00:00:00Z","timestamp":1590278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T00:00:00Z","timestamp":1590278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/4\/7-8\/2012\/NCD-II"],"award-info":[{"award-number":["5\/4\/7-8\/2012\/NCD-II"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Protoplasma"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00709-020-01513-0","type":"journal-article","created":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T00:04:00Z","timestamp":1590278640000},"page":"1259-1276","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Renal amyloidosis: an update on diagnosis and pathogenesis"],"prefix":"10.1007","volume":"257","author":[{"given":"Nimisha","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshdeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1558-8233","authenticated-orcid":false,"given":"Saima","family":"Wajid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,24]]},"reference":[{"issue":"10","key":"1513_CR1","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1182\/blood-2002-09-2707","volume":"101","author":"RS Abraham","year":"2003","unstructured":"Abraham RS, Geyer SM, Price-Troska TL, Allmer C, Kyle RA, Gertz MA, Fonseca R (2003) Immunoglobulin light chain variable (V) region genes influence clinical presentation and outcome in light chain\u2013associated amyloidosis (AL). Blood 101(10):3801\u20133807. https:\/\/doi.org\/10.1182\/blood-2002-09-2707","journal-title":"Blood"},{"issue":"12","key":"1513_CR2","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1681\/ASN.2013060651","volume":"25","author":"NK Andeen","year":"2014","unstructured":"Andeen NK, Lam DY, De Boer IH, Nicosia RF (2014) Renal ApoA-1 amyloidosis with Glu34Lys mutation and intra-amyloid lipid accumulation. J Am Soc Nephrol 25(12):2703\u20132705. https:\/\/doi.org\/10.1681\/ASN.2013060651","journal-title":"J Am Soc Nephrol"},{"key":"1513_CR3","doi-asserted-by":"publisher","unstructured":"Ansari NJJUNJUN (2016) Longest survival with renal AA amyloidosis: development of end stage renal disease after 25 years of AA amyloidosis diagnosis. 3(1):5. https:\/\/doi.org\/10.2147\/CLEP.S39981","DOI":"10.2147\/CLEP.S39981"},{"issue":"2","key":"1513_CR4","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/ki.2008.152","volume":"74","author":"MD Benson","year":"2008","unstructured":"Benson MD, James S, Scott K, Liepnieks JJ, Kluve-Beckerman B (2008) Leukocyte chemotactic factor 2: a novel renal amyloid protein. Kidney Int 74(2):218\u2013222. https:\/\/doi.org\/10.1038\/ki.2008.152","journal-title":"Kidney Int"},{"key":"1513_CR5","doi-asserted-by":"publisher","unstructured":"Benson MD, Buxbaum JN, Eisenberg DS, Merlini G, Saraiva MJM, Sekijima Y, Sipe JD, Westermark P (2019) Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid:1\u20135. https:\/\/doi.org\/10.1080\/13506129.2018.1549825","DOI":"10.1080\/13506129.2018.1549825"},{"issue":"6","key":"1513_CR6","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1136\/jnnp.56.6.694","volume":"56","author":"K Bhatia","year":"1993","unstructured":"Bhatia K, Reilly M, Adams D, Davis MB, Hawkes CH, Thomas PK, Said G, Harding AE (1993) Transthyretin gene mutations in British and French patients with amyloid neuropathy. J Neurol Neurosurg Psychiatry 56(6):694\u2013697. https:\/\/doi.org\/10.1136\/jnnp.56.6.694","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"1513_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/hmg\/ddx383","volume":"27","author":"F Bon\u00ec","year":"2018","unstructured":"Bon\u00ec F, Milani M, Barbiroli A, Diomede L, Mastrangelo E, de Rosa M (2018) Gelsolin pathogenic Gly167Arg mutation promotes domain-swap dimerization of the protein. Hum Mol Genet 27(1):53\u201365. https:\/\/doi.org\/10.1093\/hmg\/ddx383","journal-title":"Hum Mol Genet"},{"issue":"2","key":"1513_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/(sici)1098-1004(1998)12:2<135::Aid-humu10>3.0.Co;2-6","volume":"12","author":"DR Booth","year":"1998","unstructured":"Booth DR, Gillmore JD, Persey MR, Booth SE, Cafferty KD, Tennent GA, Madhoo S, Cochrane SW, Whitehead TC, Pasvol G, Hawkins PN (1998) Transthyretin Ile73Val is associated with familial amyloidotic polyneuropathy in a Bangladeshi family. Mutations in brief no. 158. Online. Hum Mutat 12(2):135. https:\/\/doi.org\/10.1002\/(sici)1098-1004(1998)12:2<135::Aid-humu10>3.0.Co;2-6","journal-title":"Hum Mutat"},{"key":"1513_CR9","doi-asserted-by":"publisher","unstructured":"Bowen K, Shah N, Lewin M (2012) AL-amyloidosis presenting with negative Congo red staining in the setting of high clinical suspicion: a case report. Case reports in nephrology, 2012. https:\/\/doi.org\/10.1155\/2012\/593460","DOI":"10.1155\/2012\/593460"},{"issue":"1\u20132","key":"1513_CR10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/prca.201200097","volume":"7","author":"F Brambilla","year":"2013","unstructured":"Brambilla F, Lavatelli F, Merlini G, Mauri P (2013) Clinical proteomics for diagnosis and typing of systemic amyloidoses. Proteomics\u2013Clin Appl 7(1\u20132):136\u2013143. https:\/\/doi.org\/10.1002\/prca.201200097","journal-title":"Proteomics\u2013Clin Appl"},{"issue":"1","key":"1513_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/jns.12153","volume":"21","author":"I Concei\u00e7\u00e3o","year":"2016","unstructured":"Concei\u00e7\u00e3o I, Gonz\u00e1lez-Duarte A, Obici L, Schmidt HHJ, Simoneau D, Ong ML, Amass L (2016) \u201cRed-flag\u201d symptom clusters in transthyretin familial amyloid polyneuropathy. J Peripher Nerv Syst 21(1):5\u20139. https:\/\/doi.org\/10.1111\/jns.12153","journal-title":"J Peripher Nerv Syst"},{"issue":"3","key":"1513_CR12","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.kint.2016.04.003","volume":"90","author":"S Dasari","year":"2016","unstructured":"Dasari S, Amin MS, Kurtin PJ, Vrana JA, Theis JD, Grogg KL, Alexander MP, Nasr SH, Fervenza FC, Leung N (2016) Clinical, biopsy, and mass spectrometry characteristics of renal apolipoprotein A-IV amyloidosis. Kidney Int 90(3):658\u2013664. https:\/\/doi.org\/10.1016\/j.kint.2016.04.003","journal-title":"Kidney Int"},{"key":"1513_CR13","doi-asserted-by":"publisher","unstructured":"de As\u00faa DR, Costa R, Galv\u00e1n JM, Filigheddu MT, Trujillo D, Cadi\u00f1anos JJC (2014) Systemic AA amyloidosis: epidemiology, diagnosis, and management. 6:369. https:\/\/doi.org\/10.2147\/CLEP.S39981","DOI":"10.2147\/CLEP.S39981"},{"key":"1513_CR14","doi-asserted-by":"publisher","unstructured":"Dember LM, Hawkins PN, Hazenberg BP, Gorevic PD, Merlini G, Butrimiene I, Livneh A, Lesnyak O, Pu\u00e9chal X, Lachmann HJJNEJM (2007) Eprodisate for the treatment of renal disease in AA amyloidosis. 356(23):2349\u20132360. https:\/\/doi.org\/10.1080\/13506129.2018.1474733","DOI":"10.1080\/13506129.2018.1474733"},{"key":"1513_CR15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1146\/annurev-pathol-052016-100","volume":"12","author":"A Dogan","year":"2017","unstructured":"Dogan A (2017) Amyloidosis: insights from proteomics. Annu Rev Pathol 12:277\u2013304. https:\/\/doi.org\/10.1146\/annurev-pathol-052016-100","journal-title":"Annu Rev Pathol"},{"key":"1513_CR16","doi-asserted-by":"publisher","unstructured":"Erdogmus S, Kendi Celebi Z, Akturk S, Kumru G, Duman N, Ates K, Erturk S, Nergizoglu G, Kutlay S, Sengul SJA (2018) Profile of renal AA amyloidosis in older and younger individuals: a single-centre experience. 25(2):115\u2013119. https:\/\/doi.org\/10.1080\/13506129.2018.1474733","DOI":"10.1080\/13506129.2018.1474733"},{"issue":"3","key":"1513_CR17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2147\/tcrm.2006.2.3.271","volume":"2","author":"A Field-Smith","year":"2006","unstructured":"Field-Smith A, Morgan GJ, Davies FE (2006) Bortezomib (Velcade\u2122) in the treatment of multiple myeloma. Ther Clin Risk Manag 2(3):271\u2013279. https:\/\/doi.org\/10.2147\/tcrm.2006.2.3.271","journal-title":"Ther Clin Risk Manag"},{"key":"1513_CR18","doi-asserted-by":"publisher","unstructured":"Fuah KW, Lim CTS (2018) Renal-limited AL amyloidosis\u2013a diagnostic and management dilemma. BMC nephrology, 19(1):307. https:\/\/doi.org\/10.1186\/s12882-018-1118-8","DOI":"10.1186\/s12882-018-1118-8"},{"issue":"216","key":"1513_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/qjmed.a067851","volume":"55","author":"J Gafni","year":"1985","unstructured":"Gafni J, Fischel B, Reif R, Yaron M, Pras M (1985) Amyloidotic polyneuropathy in a Jewish family. Evidence for the genetic heterogeneity of the lower limb familial amyloidotic neuropathies. Q J Med 55(216):33\u201344. https:\/\/doi.org\/10.1093\/qjmed.a067851","journal-title":"Q J Med"},{"key":"1513_CR20","doi-asserted-by":"publisher","unstructured":"Gilbertson JA, Theis JD, Vrana JA, Lachmann H, Wechalekar A, Whelan C, Hawkins PN, Dogan A, Gillmore JD (2015, 2014) A comparison of immunohistochemistry and mass spectrometry for determining the amyloid fibril protein from formalin-fixed biopsy tissue. J Clin Pathol:202722. https:\/\/doi.org\/10.1136\/jclinpath-2014-202722","DOI":"10.1136\/jclinpath-2014-202722"},{"key":"1513_CR21","doi-asserted-by":"publisher","unstructured":"Gillmore JD, Lachmann HJ, Rowczenio D, Gilbertson JA, Zeng C-H, Liu Z-H, Li L-S, Wechalekar A, Hawkins PNJJASN (2009) Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen A\u03b1-chain amyloidosis. 20(2):444\u2013451. https:\/\/doi.org\/10.1681\/ASN.2008060614","DOI":"10.1681\/ASN.2008060614"},{"issue":"4","key":"1513_CR22","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3109\/13506129.2012.723074","volume":"19","author":"S Girnius","year":"2012","unstructured":"Girnius S, Skinner M, Spencer B, Prokaeva T, Bartholomew C, O\u2019Hara C, Seldin DC, Connors LH (2012) A new lysozyme tyr54asn mutation causing amyloidosis in a family of Swedish ancestry with gastrointestinal symptoms. Amyloid 19(4):182\u2013185. https:\/\/doi.org\/10.3109\/13506129.2012.723074","journal-title":"Amyloid"},{"issue":"1","key":"1513_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/01.md.0000200467.51816.6d","volume":"85","author":"B Granel","year":"2006","unstructured":"Granel B, Valleix S, Serratrice J, Ch\u00e9rin P, Texeira A, Disdier P, Weiller P-J, Grateau G (2006) Lysozyme amyloidosis: report of 4 cases and a review of the literature. Medicine 85(1):66\u201373. https:\/\/doi.org\/10.1097\/01.md.0000200467.51816.6d","journal-title":"Medicine"},{"issue":"12","key":"1513_CR24","doi-asserted-by":"publisher","first-page":"3680","DOI":"10.1681\/ASN.2005040382","volume":"16","author":"G Gregorini","year":"2005","unstructured":"Gregorini G, Izzi C, Obici L, Tardanico R, R\u00f6cken C, Viola BF, Capistrano M, Donadei S, Biasi L, Scalvini T (2005) Renal apolipoprotein AI amyloidosis: a rare and usually ignored cause of hereditary tubulointerstitial nephritis. J Am Soc Nephrol 16(12):3680\u20133686. https:\/\/doi.org\/10.1681\/ASN.2005040382","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"1513_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12900-018-0088-1","volume":"18","author":"JW Griffin","year":"2018","unstructured":"Griffin JW, Bradshaw PC (2018) In silico prediction of novel residues involved in amyloid primary nucleation of human I56T and D67H lysozyme. BMC Struct Biol 18(1):9. https:\/\/doi.org\/10.1186\/s12900-018-0088-1","journal-title":"BMC Struct Biol"},{"key":"1513_CR26","doi-asserted-by":"publisher","unstructured":"Gurevitz SA, Stone MJ (2012) Amyloidosis: diagnosis and treatment edited by Morie a. Gertz, MD, and S. Vincent Rajkumar, MD. Proc (Baylor Univ Med Cent) 25 (2):166\u2013166 https:\/\/doi.org\/10.1080\/08998280.2012.11928822, 168","DOI":"10.1080\/08998280.2012.11928822"},{"issue":"1","key":"1513_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1080\/13506120410001682578","volume":"11","author":"EB Haagsma","year":"2004","unstructured":"Haagsma EB, Hawkins PN, Benson MD, Lachmann HJ, Bybee A, Hazenberg BP (2004a) Familial amyloidotic polyneuropathy with severe renal involvement in association with transthyretin Gly47Glu in Dutch, British and American-Finnish families. Amyloid 11(1):44\u201349. https:\/\/doi.org\/10.1080\/13506120410001682578","journal-title":"Amyloid"},{"issue":"1","key":"1513_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1080\/13506120410001682578","volume":"11","author":"EB Haagsma","year":"2004","unstructured":"Haagsma EB, Hawkins PN, Benson MD, Lachmann HJ, Bybee A, Hazenberg BP (2004b) Familial amyloidotic polyneuropathy with severe renal involvement in association with transthyretin Gly47Glu in Dutch, British and American-Finnish families. Amyloid 11(1):44\u201349. https:\/\/doi.org\/10.1080\/13506120410001682578","journal-title":"Amyloid"},{"key":"1513_CR29","doi-asserted-by":"publisher","unstructured":"Hassen M, Bates W, Moosa MR (2019) Pattern of renal amyloidosis in South Africa. BMC nephrology, 20(1):406. https:\/\/doi.org\/10.1186\/s12882-019-1601-x","DOI":"10.1186\/s12882-019-1601-x"},{"issue":"9","key":"1513_CR30","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1093\/ndt\/gfq83","volume":"26","author":"H Hopfer","year":"2011","unstructured":"Hopfer H, Wiech T, Mihatsch MJ (2011) Renal amyloidosis revisited: amyloid distribution, dynamics and biochemical type. Nephrol Dial Transplant 26(9):2877\u20132884. https:\/\/doi.org\/10.1093\/ndt\/gfq83","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"1513_CR31","first-page":"121","volume":"56","author":"S Ikeda","year":"2008","unstructured":"Ikeda S (2008) Diagnosis and treatment in systemic amyloidosis. Rinsho byori. Jpn J Clin Pathol 56(2):121\u2013129","journal-title":"Jpn J Clin Pathol"},{"key":"1513_CR32","unstructured":"Jimenez-Zepeda VH, Leung NJRIC (2014) ALECT2 amyloidosis: a new type of systemic amyloid highly prevalent in the Hispanic population 66(3):269\u2013273"},{"issue":"7","key":"1513_CR33","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.metabol.2011.12.002","volume":"61","author":"AA Kei","year":"2012","unstructured":"Kei AA, Filippatos TD, Tsimihodimos V, Elisaf MS (2012) A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease. Metabolism 61(7):906\u2013921. https:\/\/doi.org\/10.1016\/j.metabol.2011.12.002","journal-title":"Metabolism"},{"issue":"4","key":"1513_CR34","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/13506120701616383","volume":"14","author":"AV Kristen","year":"2007","unstructured":"Kristen AV, Ehlermann P, Helmke B, Hund E, Haberkorn U, Linke RP, Katus HA, Winter P, Altland K, Dengler TJ (2007) Transthyretin valine-94-alanine, a novel variant associated with late-onset systemic amyloidosis with cardiac involvement. Amyloid 14(4):283\u2013287. https:\/\/doi.org\/10.1080\/13506120701616383","journal-title":"Amyloid"},{"issue":"1","key":"1513_CR35","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2217\/nmt-2018-0033","volume":"9","author":"AV Kristen","year":"2019","unstructured":"Kristen AV, Ajroud-Driss S, Concei\u00e7\u00e3o I, Gorevic P, Kyriakides T, Obici L (2019) Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis. Neurodegenerat Dis Manag 9(1):5\u201323","journal-title":"Neurodegenerat Dis Manag"},{"key":"1513_CR36","doi-asserted-by":"publisher","unstructured":"Kulkarni U, Valson A, Korula A, Mathews V (2015) Leukocyte derived chemotaxin 2 (ALECT2) amyloidosis. Mediterr J Hematol Infect Dis 7(1). https:\/\/doi.org\/10.4084\/MJHID.2015.043","DOI":"10.4084\/MJHID.2015.043"},{"issue":"23","key":"1513_CR37","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1056\/NEJMoa070265","volume":"356","author":"HJ Lachmann","year":"2007","unstructured":"Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, Hawkins PNJNEJM (2007) Natural history and outcome in systemic AA amyloidosis. N Engl J Med 356(23):2361\u20132371. https:\/\/doi.org\/10.1056\/NEJMoa070265","journal-title":"N Engl J Med"},{"key":"1513_CR38","doi-asserted-by":"publisher","unstructured":"Lane T, Pinney JH, Gilbertson JA, Hutt DF, Rowczenio DM, Mahmood S, Sachchithanantham S, Fontana M, Youngstein T, Quarta CCJA (2017) Changing epidemiology of AA amyloidosis: clinical observations over 25 years at a single national referral centre. 24(3):162\u2013166. https:\/\/doi.org\/10.1080\/13506129.2017.1342235","DOI":"10.1080\/13506129.2017.1342235"},{"issue":"2","key":"1513_CR39","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/ki.2014.11","volume":"86","author":"CP Larsen","year":"2014","unstructured":"Larsen CP, Kossmann RJ, Beggs ML, Solomon A, Walker PD (2014) Clinical, morphologic, and genetic features of renal leukocyte chemotactic factor 2 amyloidosis. Kidney Int 86(2):378\u2013382. https:\/\/doi.org\/10.1038\/ki.2014.11","journal-title":"Kidney Int"},{"issue":"4","key":"1513_CR40","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/modpathol.2016.29","volume":"29","author":"CP Larsen","year":"2016","unstructured":"Larsen CP, Ismail W, Kurtin PJ, Vrana JA, Dasari S, Nasr SH (2016) Leukocyte chemotactic factor 2 amyloidosis (ALECT2) is a common form of renal amyloidosis among Egyptians. Mod Pathol 29(4):416\u2013420. https:\/\/doi.org\/10.1038\/modpathol.2016.29","journal-title":"Mod Pathol"},{"issue":"7","key":"1513_CR41","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1080\/14789450.2017.1331737","volume":"14","author":"F Lavatelli","year":"2017","unstructured":"Lavatelli F, Merlini G (2017) How do we improve treatments for patients with amyloidosis using proteomics? Expert Rev Proteomics 14(7):561\u2013563. https:\/\/doi.org\/10.1080\/14789450.2017.1331737","journal-title":"Expert Rev Proteomics"},{"issue":"4","key":"1513_CR42","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3109\/13506129.2011.630762","volume":"18","author":"F Lavatelli","year":"2011","unstructured":"Lavatelli F, Vrana JA (2011) Proteomic typing of amyloid deposits in systemic amyloidoses. Amyloid 18(4):177\u2013182. https:\/\/doi.org\/10.3109\/13506129.2011.630762","journal-title":"Amyloid"},{"key":"1513_CR43","first-page":"2003","volume":"2012","author":"N Leung","year":"2012","unstructured":"Leung N, Nasr SH, Sethi S (2012) How I diagnose amyloidosis. Blood 2012:2003\u2013413682","journal-title":"Blood"},{"issue":"1","key":"1513_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-019-1496-6","volume":"20","author":"Z Li","year":"2019","unstructured":"Li Z, Xu H, Liu D, Li D, Liu G, Wang S-x (2019a) Hereditary renal amyloidosis with a variant lysozyme p. Trp82Arg in a Chinese family: case report and literature review. BMC Nephrol 20(1):1\u20136. https:\/\/doi.org\/10.1186\/s12882-019-1496-6","journal-title":"BMC Nephrol"},{"issue":"1","key":"1513_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-019-1667-5","volume":"20","author":"D Li","year":"2019","unstructured":"Li D, Liu D, Xu H, Yu X-j, M-h Z, Wang S-x (2019b) Typing of hereditary renal amyloidosis presenting with isolated glomerular amyloid deposition. BMC Nephrol 20(1):1\u20138. https:\/\/doi.org\/10.1186\/s12882-019-1667-5","journal-title":"BMC Nephrol"},{"issue":"8","key":"1513_CR46","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1110\/ps.0349703","volume":"12","author":"A Lim","year":"2003","unstructured":"Lim A, Prokaeva T, McComb ME, Connors LH, Skinner M, Costello CE (2003) Identification of S-sulfonation and S-thiolation of a novel transthyretin Phe33Cys variant from a patient diagnosed with familial transthyretin amyloidosis. Prot Sci 12(8):1775\u20131785. https:\/\/doi.org\/10.1110\/ps.0349703","journal-title":"Prot Sci"},{"issue":"2","key":"1513_CR47","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2174\/157016306778108866","volume":"3","author":"J-C Lin","year":"2006","unstructured":"Lin J-C, Liu H-L (2006) Protein conformational diseases: from mechanisms to drug designs. Curr Drug Discov Technol 3(2):145\u2013153. https:\/\/doi.org\/10.2174\/157016306778108866","journal-title":"Curr Drug Discov Technol"},{"issue":"1\u20132","key":"1513_CR48","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jns.2011.02.005","volume":"304","author":"JY Liu","year":"2011","unstructured":"Liu JY, Guo YJ, Zhou CK, Ye YQ, Feng JQ, Yin F, Jiang XM (2011) Clinical and histopathological features of familial amyloidotic polyneuropathy with transthyretin Val30Ala in a Chinese family. J Neurol Sci 304(1\u20132):83\u201386. https:\/\/doi.org\/10.1016\/j.jns.2011.02.005","journal-title":"J Neurol Sci"},{"issue":"8","key":"1513_CR49","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.2215\/CJN.08720811","volume":"7","author":"L Lobato","year":"2012","unstructured":"Lobato L, Rocha A (2012a) Transthyretin amyloidosis and the kidney. Clin J Am Soc Nephrol 7(8):1337\u20131346. https:\/\/doi.org\/10.2215\/CJN.08720811","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"1513_CR50","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.2215\/cjn.08720811","volume":"7","author":"L Lobato","year":"2012","unstructured":"Lobato L, Rocha A (2012b) Transthyretin amyloidosis and the kidney. Clin J Am Soc Nephrol 7(8):1337\u20131346. https:\/\/doi.org\/10.2215\/cjn.08720811","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"1513_CR51","doi-asserted-by":"publisher","first-page":"205427041664015","DOI":"10.1177\/2054270416640156","volume":"7","author":"A Logan","year":"2016","unstructured":"Logan A, Zuppan C, Pi A, Zhang Z, Jaipaul N (2016) Rare and unusual clinicopathologic presentation of renal AL amyloidosis. JRSM open 7(5):2054270416640156. https:\/\/doi.org\/10.1177\/2054270416640156","journal-title":"JRSM open"},{"issue":"39","key":"1513_CR52","doi-asserted-by":"publisher","first-page":"e8148","DOI":"10.1097\/MD.0000000000008148","volume":"96","author":"C Lu","year":"2017","unstructured":"Lu C, Zuo K, Lu Y, Liang S, Huang X, Zeng C, Zhang J, An Y, Wang J (2017) Apolipoprotein A-1-related amyloidosis 2 case reports and review of the literature. Medicine 96(39):e8148. https:\/\/doi.org\/10.1097\/MD.0000000000008148","journal-title":"Medicine"},{"issue":"3","key":"1513_CR53","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.ekir.2017.11.017","volume":"3","author":"P Milani","year":"2018","unstructured":"Milani P, Merlini G, Palladini G (2018) Novel therapies in light chain amyloidosis. Kidney Int Rep 3(3):530\u2013541. https:\/\/doi.org\/10.1016\/j.ekir.2017.11.017","journal-title":"Kidney Int Rep"},{"key":"1513_CR54","doi-asserted-by":"publisher","unstructured":"Nasr SH, Dogan A, Larsen CPJCJASN (2015) Leukocyte cell\u2013derived chemotaxin 2\u2013associated amyloidosis: A recently recognized disease with distinct clinicopathologic characteristics. 10(11):2084\u20132093. https:\/\/doi.org\/10.2215\/CJN.12551214","DOI":"10.2215\/CJN.12551214"},{"issue":"2","key":"1513_CR55","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1681\/ASN.2015111228","volume":"28","author":"SH Nasr","year":"2017","unstructured":"Nasr SH, Dasari S, Hasadsri L, Theis JD, Vrana JA, Gertz MA, Muppa P, Zimmermann MT, Grogg KL, Dispenzieri A (2017a) Novel type of renal amyloidosis derived from apolipoprotein-CII. J Am Soc Nephrol 28(2):439\u2013445. https:\/\/doi.org\/10.1681\/ASN.2015111228","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1513_CR56","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1681\/ASN.2016090951","volume":"28","author":"SH Nasr","year":"2017","unstructured":"Nasr SH, Dasari S, Mills JR, Theis JD, Zimmermann MT, Fonseca R, Vrana JA, Lester SJ, McLaughlin BM, Gillespie R (2017b) Hereditary lysozyme amyloidosis variant p. Leu102Ser associates with unique phenotype. J Am Soc Nephrol 28(2):431\u2013438. https:\/\/doi.org\/10.1681\/ASN.2016090951","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1513_CR57","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1681\/asn.2016090951","volume":"28","author":"SH Nasr","year":"2017","unstructured":"Nasr SH, Dasari S, Mills JR, Theis JD, Zimmermann MT, Fonseca R, Vrana JA, Lester SJ, McLaughlin BM, Gillespie R, Highsmith WE Jr, Lee JJ, Dispenzieri A, Kurtin PJ (2017c) Hereditary lysozyme amyloidosis variant p.Leu102Ser associates with unique phenotype. J Am Soc Nephrol 28(2):431\u2013438. https:\/\/doi.org\/10.1681\/asn.2016090951","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1513_CR58","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.kint.2016.05.029","volume":"90","author":"L Obici","year":"2016","unstructured":"Obici L, Nuvolone M, Merlini G (2016) Expanding the spectrum of systemic amyloid diseases: a new hint from the kidney. Kidney Int 90(3):479\u2013481. https:\/\/doi.org\/10.1016\/j.kint.2016.05.029","journal-title":"Kidney Int"},{"issue":"1","key":"1513_CR59","first-page":"68","volume":"62","author":"S Ong","year":"2007","unstructured":"Ong S, Rajasingam R (2007) Abdominal subcutaneous fat aspiration\u2014an alternative method to diagnose amyloidosis. Med J Malaysia 62(1):68\u201369","journal-title":"Med J Malaysia"},{"key":"1513_CR60","doi-asserted-by":"publisher","unstructured":"Papa R, Lachmann HJJRDC (2018) Secondary, AA, amyloidosis. 44(4):585\u2013603. https:\/\/doi.org\/10.1016\/j.rdc.2018.06.004","DOI":"10.1016\/j.rdc.2018.06.004"},{"issue":"1","key":"1513_CR61","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3109\/13506120209072443","volume":"9","author":"E Pelo","year":"2002","unstructured":"Pelo E, Da Prato L, Ciaccheri M, Castelli G, Gori F, Pizzi A, Torricelli F, Marconi G (2002) Familial amyloid polyneuropathy with genetic anticipation associated to a gly47glu transthyretin variant in an Italian kindred. Amyloid 9(1):35\u201341. https:\/\/doi.org\/10.3109\/13506120209072443","journal-title":"Amyloid"},{"issue":"6420","key":"1513_CR62","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/362553a0","volume":"362","author":"M Pepys","year":"1993","unstructured":"Pepys M, Hawkins P, Booth D, Vigushin D, Tennent G, Soutar A, Totty N, Nguyen O, Blake C, Terry C (1993) Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature 362(6420):553\u2013557. https:\/\/doi.org\/10.1038\/362553a0","journal-title":"Nature"},{"issue":"4","key":"1513_CR63","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1043\/1543-2165-134.4.545","volume":"134","author":"MM Picken","year":"2010","unstructured":"Picken MM (2010) Amyloidosis\u2014where are we now and where are we heading? Arch Pathol Lab Med 134(4):545\u2013551. https:\/\/doi.org\/10.1043\/1543-2165-134.4.545","journal-title":"Arch Pathol Lab Med"},{"key":"1513_CR64","doi-asserted-by":"publisher","unstructured":"Picken MMJK (2014) Alect2 amyloidosis: primum non nocere (first, do no harm). 86(2):229\u2013232. https:\/\/doi.org\/10.1038\/ki.2014.45","DOI":"10.1038\/ki.2014.45"},{"issue":"6","key":"1513_CR65","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/ckj\/sfv087","volume":"8","author":"MM Picken","year":"2015","unstructured":"Picken MM (2015) Proteomics and mass spectrometry in the diagnosis of renal amyloidosis. Clin Kidney J 8(6):665\u2013672. https:\/\/doi.org\/10.1093\/ckj\/sfv087","journal-title":"Clin Kidney J"},{"key":"1513_CR66","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5414\/CNCS108538","volume":"3","author":"C Pleyer","year":"2015","unstructured":"Pleyer C, Flesche J, Saeed F (2015) Lysozyme amyloidosis\u2014a case report and review of the literature. Clin Nephrol Case Stud 3:42. https:\/\/doi.org\/10.5414\/CNCS108538","journal-title":"Clin Nephrol Case Stud"},{"issue":"6","key":"1513_CR67","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.ekir.2017.07.009","volume":"2","author":"T Prokaeva","year":"2017","unstructured":"Prokaeva T, Akar H, Spencer B, Havasi A, Cui H, O\u2019Hara CJ, Gursky O, Leszyk J, Steffen M, Browning S (2017) Hereditary renal amyloidosis associated with a novel apolipoprotein A-II variant. Kidney Int Rep 2(6):1223\u20131232. https:\/\/doi.org\/10.1016\/j.ekir.2017.07.009","journal-title":"Kidney Int Rep"},{"issue":"10","key":"1513_CR68","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1182\/bloodadvances.2018016402","volume":"2","author":"TP Quock","year":"2018","unstructured":"Quock TP, Yan T, Chang E, Guthrie S, Broder MSJB (2018) Epidemiology of AL amyloidosis: a real-world study using US claims data. Blood Adv 2(10):1046\u20131053. https:\/\/doi.org\/10.1182\/bloodadvances.2018016402","journal-title":"Blood Adv"},{"issue":"4","key":"1513_CR69","first-page":"211","volume":"8","author":"S Reitamo","year":"1978","unstructured":"Reitamo S, Klockars M, Adinolfi M, Osserman E (1978) Human lysozyme (origin and distribution in health and disease). La Ricerca in Clinica e in Laboratorio 8(4):211\u2013231","journal-title":"La Ricerca in Clinica e in Laboratorio"},{"issue":"2","key":"1513_CR70","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/ndt\/gfw375","volume":"33","author":"T Rezk","year":"2016","unstructured":"Rezk T, Gilbertson JA, Rowczenio D, Bass P, Lachmann HJ, Wechalekar AD, Fontana M, Mahmood S, Sachchithanantham S, Whelan CJ (2016) Diagnosis, pathogenesis and outcome in leucocyte chemotactic factor 2 (ALECT2) amyloidosis. Nephrol Dial Transplant 33(2):241\u2013247. https:\/\/doi.org\/10.1093\/ndt\/gfw375","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"1513_CR71","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1159\/00032492","volume":"3","author":"G Riboldi","year":"2011","unstructured":"Riboldi G, Del Bo R, Ranieri M, Magri F, Sciacco M, Moggio M, Bresolin N, Corti S, Comi GP (2011) Tyr78Phe transthyretin mutation with predominant motor neuropathy as the initial presentation. Case Rep Neurol 3(1):62\u201368. https:\/\/doi.org\/10.1159\/00032492","journal-title":"Case Rep Neurol"},{"issue":"1","key":"1513_CR72","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/humu.9393","volume":"27","author":"C R\u00f6cken","year":"2006","unstructured":"R\u00f6cken C, Becker K, F\u00e4ndrich M, Schroeckh V, Stix B, Rath T, K\u00e4hne T, Dierkes J, Roessner A, Albert FW (2006) ALys amyloidosis caused by compound heterozygosity in exon 2 (Thr70Asn) and exon 4 (Trp112Arg) of the lysozyme gene. Hum Mutat 27(1):119\u2013120. https:\/\/doi.org\/10.1002\/humu.9393","journal-title":"Hum Mutat"},{"issue":"2","key":"1513_CR73","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3109\/0886022X.2015.1128252","volume":"38","author":"G Rona","year":"2016","unstructured":"Rona G, Pasaoglu L, Ozkayar N, Ciliz D, Toprak U, Kaya T, Abat G (2016) Functional evaluation of secondary renal amyloidosis with diffusion-weighted MR imaging. Ren Fail 38(2):249\u2013255. https:\/\/doi.org\/10.3109\/0886022X.2015.1128252","journal-title":"Ren Fail"},{"issue":"4","key":"1513_CR74","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3109\/13506129.2014.973105","volume":"21","author":"D Rowczenio","year":"2014","unstructured":"Rowczenio D, Tennent GA, Gilbertson J, Lachmann HJ, Hutt DF, Bybee A, Hawkins PN, Gillmore JD (2014) Clinical characteristics and SAP scintigraphic findings in 10 patients with AGel amyloidosis. Amyloid 21(4):276\u2013281. https:\/\/doi.org\/10.3109\/13506129.2014.973105","journal-title":"Amyloid"},{"issue":"3","key":"1513_CR75","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.ekir.2016.11.005","volume":"2","author":"D Rowczenio","year":"2017","unstructured":"Rowczenio D, Stensland M, de Souza GA, Str\u00f8m EH, Gilbertson JA, Taylor G, Rendell N, Minogue S, Efebera YA, Lachmann HJ (2017) Renal amyloidosis associated with 5 novel variants in the fibrinogen a alpha chain protein. Kidney Int Rep 2(3):461\u2013469. https:\/\/doi.org\/10.1016\/j.ekir.2016.11.005","journal-title":"Kidney Int Rep"},{"key":"1513_CR76","doi-asserted-by":"publisher","unstructured":"Said SM, Sethi S, Valeri AM, Leung N, Cornell LD, Fidler ME, Hernandez LH, Vrana JA, Theis JD, Quint PSJCJASN (2013) Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases. CJN:10491012. https:\/\/doi.org\/10.2215\/CJN.10491012","DOI":"10.2215\/CJN.10491012"},{"issue":"2","key":"1513_CR77","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/ki.2013.558","volume":"86","author":"SM Said","year":"2014","unstructured":"Said SM, Sethi S, Valeri AM, Chang A, Nast CC, Krahl L, Molloy P, Barry M, Fidler ME, Cornell LD (2014) Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis. Kidney Int 86(2):370\u2013377. https:\/\/doi.org\/10.1038\/ki.2013.558","journal-title":"Kidney Int"},{"issue":"2","key":"1513_CR78","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1053\/hupa.2001.22013","volume":"32","author":"F Saito","year":"2001","unstructured":"Saito F, Nakazato M, Akiyama H, Kitahara Y, Date Y, Iwasaki Y, Harasawa S, Hisaki R, Horie T, Kinukawa N, Watanabe T, Sakamaki T, Yagi H, Hoshii Y, Yutani C, Kanmatsuse K (2001) A case of late onset cardiac amyloidosis with a new transthyretin variant (lysine 92). Hum Pathol 32(2):237\u2013239. https:\/\/doi.org\/10.1053\/hupa.2001.22013","journal-title":"Hum Pathol"},{"issue":"6","key":"1513_CR79","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1172\/jci112224","volume":"76","author":"MJ Saraiva","year":"1985","unstructured":"Saraiva MJ, Costa PP, Goodman DS (1985) Biochemical marker in familial amyloidotic polyneuropathy, Portuguese type. Family studies on the transthyretin (prealbumin)-methionine-30 variant. J Clin Invest 76(6):2171\u20132177. https:\/\/doi.org\/10.1172\/jci112224","journal-title":"J Clin Invest"},{"issue":"1","key":"1513_CR80","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1365-2796.2011.02470.x","volume":"272","author":"P Sattianayagam","year":"2012","unstructured":"Sattianayagam P, Gibbs S, Rowczenio D, Pinney J, Wechalekar A, Gilbertson J, Hawkins P, Lachmann H, Gillmore J (2012) Hereditary lysozyme amyloidosis\u2013phenotypic heterogeneity and the role of solid organ transplantation. J Intern Med 272(1):36\u201344. https:\/\/doi.org\/10.1111\/j.1365-2796.2011.02470.x","journal-title":"J Intern Med"},{"key":"1513_CR81","doi-asserted-by":"publisher","unstructured":"Scafi M, Valleix S, Benyamine A, Jean E, Harle JR, Rossi P, Daniel L, Schleinitz N, Granel B (2018) Lysozyme amyloidosis. Rev Med Interne. https:\/\/doi.org\/10.1016\/j.revmed.2018.08.008","DOI":"10.1016\/j.revmed.2018.08.008"},{"key":"1513_CR82","doi-asserted-by":"publisher","unstructured":"Sethi S, Theis JD (2018) Pathology and diagnosis of renal non-AL amyloidosis. J Nephrol:1\u20138. https:\/\/doi.org\/10.1007\/s40620-017-0426-6","DOI":"10.1007\/s40620-017-0426-6"},{"issue":"12","key":"1513_CR83","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.2215\/CJN.02890310","volume":"5","author":"S Sethi","year":"2010","unstructured":"Sethi S, Theis JD, Leung N, Dispenzieri A, Nasr SH, Fidler ME, Cornell LD, Gamez JD, Vrana JA, Dogan A (2010) Mass spectrometry\u2013based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis. Clin J Am Soc Nephrol 5(12):2180\u20132187. https:\/\/doi.org\/10.2215\/CJN.02890310","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"1513_CR84","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/ki.2012.108","volume":"82","author":"S Sethi","year":"2012","unstructured":"Sethi S, Vrana JA, Theis JD, Leung N, Sethi A, Nasr SH, Fervenza FC, Cornell LD, Fidler ME, Dogan A (2012a) Laser microdissection and mass spectrometry\u2013based proteomics aids the diagnosis and typing of renal amyloidosis. Kidney Int 82(2):226\u2013234. https:\/\/doi.org\/10.1038\/ki.2012.108","journal-title":"Kidney Int"},{"issue":"2","key":"1513_CR85","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/ki.2011.316","volume":"81","author":"S Sethi","year":"2012","unstructured":"Sethi S, Theis JD, Shiller SM, Nast CC, Harrison D, Rennke HG, Vrana JA, Dogan A (2012b) Medullary amyloidosis associated with apolipoprotein A-IV deposition. Kidney Int 81(2):201\u2013206. https:\/\/doi.org\/10.1038\/ki.2011.316","journal-title":"Kidney Int"},{"issue":"4","key":"1513_CR86","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.kint.2016.11.017","volume":"91","author":"S Sethi","year":"2017","unstructured":"Sethi S, Dasari S, Amin MS, Vrana JA, Theis JD, Alexander MP, Kurtin PJ (2017) Clinical, biopsy, and mass spectrometry findings of renal gelsolin amyloidosis. Kidney Int 91(4):964\u2013971. https:\/\/doi.org\/10.1016\/j.kint.2016.11.017","journal-title":"Kidney Int"},{"key":"1513_CR87","doi-asserted-by":"publisher","unstructured":"Sethi S, Dasari S, Plaisier E, Ronco P, Nasr SH, Brocheriou I, Theis JD, Vrana JA, Zimmermann MT, Quint PS (2018) Apolipoprotein CII amyloidosis associated with p. Lys41Thr mutation. Kidney International Reports https:\/\/doi.org\/10.1016\/j.ekir.2018.04.009","DOI":"10.1016\/j.ekir.2018.04.009"},{"key":"1513_CR88","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.biochi.2016.04.020","volume":"127","author":"V Sivalingam","year":"2016","unstructured":"Sivalingam V, Patel BK (2016) Familial mutations in fibrinogen A\u03b1 (FGA) chain identified in renal amyloidosis increase in vitro amyloidogenicity of FGA fragment. Biochimie 127:44\u201349. https:\/\/doi.org\/10.1016\/j.biochi.2016.04.020","journal-title":"Biochimie"},{"issue":"3","key":"1513_CR89","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3109\/10409238.2012.661401","volume":"47","author":"JP Solomon","year":"2012","unstructured":"Solomon JP, Page LJ, Balch WE, Kelly JW (2012) Gelsolin amyloidosis: genetics, biochemistry, pathology and possible strategies for therapeutic intervention. Crit Rev Biochem Mol Biol 47(3):282\u2013296. https:\/\/doi.org\/10.3109\/10409238.2012.661401","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"16","key":"1513_CR90","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1021\/acs.biochem.8b00039","volume":"57","author":"A Srivastava","year":"2018","unstructured":"Srivastava A, Singh J, Singh Yadav SP, Arya P, Kalim F, Rose P, Ashish KB (2018) The gelsolin pathogenic D187N mutant exhibits altered conformational stability and forms amyloidogenic oligomers. Biochemistry 57(16):2359\u20132372. https:\/\/doi.org\/10.1021\/acs.biochem.8b00039","journal-title":"Biochemistry"},{"issue":"sup1","key":"1513_CR91","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3109\/13506129.2012.674075","volume":"19","author":"Y Su","year":"2012","unstructured":"Su Y, Jono H, Torikai M, Hosoi A, Soejima K, Guo J, Tasaki M, Misumi Y, Ueda M, Shinriki S (2012) Antibody therapy for familial amyloidotic polyneuropathy. Amyloid 19(sup1):45\u201346. https:\/\/doi.org\/10.3109\/13506129.2012.674075","journal-title":"Amyloid"},{"issue":"3","key":"1513_CR92","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/1066896917735893","volume":"26","author":"H Tariq","year":"2018","unstructured":"Tariq H, Sharkey FE (2018) Leukocyte cell-derived chemotaxin-2 amyloidosis (ALECT2) in a patient with lung adenocarcinoma: an autopsy report and literature review. Int J Surg Pathol 26(3):271\u2013275. https:\/\/doi.org\/10.1177\/1066896917735893","journal-title":"Int J Surg Pathol"},{"key":"1513_CR93","doi-asserted-by":"publisher","first-page":"S550","DOI":"10.3109\/13506129.2015.1037389","volume":"102","author":"I Tavares","year":"2018","unstructured":"Tavares I, Silvano J, Pereira PR, Silva R, Lobato L, Henriques AC, Escada L, Macario F, Sampaio S (2018) Renal transplantation in patients with hereditary fibrinogen amyloidosis. Transplantation 102:S550\u2013S144. https:\/\/doi.org\/10.3109\/13506129.2015.1037389","journal-title":"Transplantation"},{"issue":"2","key":"1513_CR94","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1172\/JCI117027","volume":"93","author":"T Uemichi","year":"1994","unstructured":"Uemichi T, Liepnieks JJ, Benson MD (1994) Hereditary renal amyloidosis with a novel variant fibrinogen. J Clin Invest 93(2):731\u2013736. https:\/\/doi.org\/10.1172\/JCI117027","journal-title":"J Clin Invest"},{"issue":"3","key":"1513_CR95","doi-asserted-by":"publisher","first-page":"907","DOI":"10.5414\/CNCS10853810.1046\/j.1523-1755.2002.00205.x","volume":"61","author":"S Valleix","year":"2002","unstructured":"Valleix S, Drunat S, Philit J-B, Adoue D, Piette J-C, Droz D, MacGregor B, Canet D, Delpech M, Grateau G (2002) Hereditary renal amyloidosis caused by a new variant lysozyme W64R in a French family. Kidney Int 61(3):907\u2013912. https:\/\/doi.org\/10.5414\/CNCS10853810.1046\/j.1523-1755.2002.00205.x","journal-title":"Kidney Int"},{"key":"1513_CR96","doi-asserted-by":"publisher","first-page":"10353","DOI":"10.1038\/ncomms10353","volume":"7","author":"S Valleix","year":"2016","unstructured":"Valleix S, Verona G, Jourde-Chiche N, N\u00e9delec B, Mangione PP, Bridoux F, Mang\u00e9 A, Dogan A, Goujon J-M, Lhomme M (2016) D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile. Nat Commun 7:10353. https:\/\/doi.org\/10.1038\/ncomms10353","journal-title":"Nat Commun"},{"issue":"9","key":"1513_CR97","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1093\/hmg\/ddv010","volume":"24","author":"W Van Overbeke","year":"2015","unstructured":"Van Overbeke W, Wongsantichon J, Everaert I, Verhelle A, Zwaenepoel O, Loonchanta A, Burtnick LD, De Ganck A, Hochepied T, Haigh J (2015) An ER-directed gelsolin nanobody targets the first step in amyloid formation in a gelsolin amyloidosis mouse model. Hum Mol Genet 24(9):2492\u20132507. https:\/\/doi.org\/10.1093\/hmg\/ddv010","journal-title":"Hum Mol Genet"},{"issue":"1","key":"1513_CR98","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1172\/jci113293","volume":"81","author":"MR Wallace","year":"1988","unstructured":"Wallace MR, Dwulet FE, Williams EC, Conneally PM, Benson MD (1988) Identification of a new hereditary amyloidosis prealbumin variant, Tyr-77, and detection of the gene by DNA analysis. J Clin Invest 81(1):189\u2013193. https:\/\/doi.org\/10.1172\/jci113293","journal-title":"J Clin Invest"},{"key":"1513_CR99","doi-asserted-by":"publisher","unstructured":"Weisel JW (2005) Fibrinogen and fibrin. In: advances in protein chemistry, vol 70. Elsevier, pp 247\u2013299. https:\/\/doi.org\/10.1016\/S0065-3233(05)70008-5","DOI":"10.1016\/S0065-3233(05)70008-5"},{"key":"1513_CR100","doi-asserted-by":"publisher","unstructured":"Weisel JW, Litvinov RI (2013, 2012) Mechanisms of fibrin polymerization and clinical implications. Blood:2009\u2013306639. https:\/\/doi.org\/10.1182\/blood-2012-09-306639","DOI":"10.1182\/blood-2012-09-306639"},{"issue":"30","key":"1513_CR101","doi-asserted-by":"publisher","first-page":"9700","DOI":"10.1021\/bi960920n","volume":"35","author":"D Wen","year":"1996","unstructured":"Wen D, Corina K, Chow EP, Miller S, Janmey PA, Pepinsky RB (1996) The plasma and cytoplasmic forms of human gelsolin differ in disulfide structure. Biochemistry 35(30):9700\u20139709. https:\/\/doi.org\/10.1021\/bi960920n","journal-title":"Biochemistry"},{"key":"1513_CR102","doi-asserted-by":"publisher","unstructured":"Wooliver C, Coriu D, Murphy C, Kestler D, Wang S, Weiss D, Solomon A Familial amyloidosis associated with a novel mutation (D68G) in the lysozyme gene. In: XIth Int Symp Amyloidosis, 2008. pp 208\u2013210 https:\/\/doi.org\/10.1201\/9781420043358.ch70","DOI":"10.1201\/9781420043358.ch70"},{"issue":"1","key":"1513_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13256-018-1931-5","volume":"12","author":"H Yamamoto","year":"2018","unstructured":"Yamamoto H, Hashimoto T, Kawamura S, Hiroe M, Yamashita T, Ando Y, Yokochi T (2018) Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report. J Med Case Rep 12(1):1\u20135. https:\/\/doi.org\/10.1186\/s13256-018-1931-5","journal-title":"J Med Case Rep"},{"issue":"2","key":"1513_CR104","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/ckj\/sft007","volume":"6","author":"S Yamanaka","year":"2013","unstructured":"Yamanaka S, Miyazaki Y, Kasai K, S-i I, Kiuru-Enari S, Hosoya T (2013) Hereditary renal amyloidosis caused by a heterozygous G654A gelsolin mutation: a report of two cases. Clin Kidney J 6(2):189\u2013193. https:\/\/doi.org\/10.1093\/ckj\/sft007","journal-title":"Clin Kidney J"},{"issue":"5","key":"1513_CR105","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1046\/j.1523-1755.2003.00904.x","volume":"63","author":"M Yazaki","year":"2003","unstructured":"Yazaki M, Farrell SA, Benson MD (2003) A novel lysozyme mutation Phe57Ile associated with hereditary renal amyloidosis. Kidney Int 63(5):1652\u20131657. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00904.x","journal-title":"Kidney Int"},{"issue":"2","key":"1513_CR106","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3109\/13506129.2015.1037389","volume":"22","author":"M Yazaki","year":"2015","unstructured":"Yazaki M, Yoshinaga T, Sekijima Y, Nishio S, Kanizawa Y, Kametani F, Miyashita K, Hachiya N, Higuchi K, S-i I (2015) The first pure form of Ostertag-type amyloidosis in Japan: a sporadic case of hereditary fibrinogen A \u03b1-chain amyloidosis associated with a novel frameshift variant. Amyloid 22(2):142\u2013144. https:\/\/doi.org\/10.3109\/13506129.2015.1037389","journal-title":"Amyloid"},{"issue":"1","key":"1513_CR107","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3390\/ijms19010320","volume":"19","author":"M Yazaki","year":"2018","unstructured":"Yazaki M, Yoshinaga T, Sekijima Y, Kametani F, Okumura N (2018) Hereditary fibrinogen A\u03b1-chain amyloidosis in Asia: clinical and molecular characteristics. Int J Mol Sci 19(1):320. https:\/\/doi.org\/10.3390\/ijms19010320","journal-title":"Int J Mol Sci"}],"container-title":["Protoplasma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00709-020-01513-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00709-020-01513-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00709-020-01513-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,23]],"date-time":"2021-05-23T19:22:21Z","timestamp":1621797741000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00709-020-01513-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,24]]},"references-count":107,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["1513"],"URL":"https:\/\/doi.org\/10.1007\/s00709-020-01513-0","relation":{},"ISSN":["0033-183X","1615-6102"],"issn-type":[{"value":"0033-183X","type":"print"},{"value":"1615-6102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,24]]},"assertion":[{"value":"27 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All authors read the finalized manuscript and gave their consent for its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}